Risk factors of multi-drug resistant tuberculosis in urban Allahabad, India
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20172828Keywords:
Risk factors, MDR-TB, AllahabadAbstract
Background: India has the highest burden of tuberculosis globally while second highest in estimated MDR-TB cases after China. The prevalence of MDR-TB is estimated to be 3% among new cases and 14-17% amongst the re-treatment cases. The Objective of the study was to identify the risk factors of MDR-TB in patients registered at tuberculosis units of urban Allahabad.
Methods: A cross-sectional study was carried out on TB patients registered at the urban tuberculosis units of Allahabad district in the year 2015. A total of 54 MDR-TB and 1016 non-MDR TB patients were included in the study. A pre-tested structured questionnaire was used to collect the data on the various factors. The chi-square test was used to study the association of various risk factors for MDR-TB patients.
Results: MDR-TB was more common in 26-45 year age group (59.26%), males (62.96%), previously treated TB case (83.34%), positive history of contact with MDR-TB patient (5.55%), patients previously on non-DOTS treatment (37.78%), patients with associated co-morbidities (37.03%) and in substance abuse (74.07%) while Non-MDR is more common in >45 years (46.75%) age group, females (56.69%), new cases (87.20%), patients on DOTS therapy (85.16%), without any co-morbidities (83.46%) and in patients having positive history of substance abuse (60.04%).
Conclusions: The younger age, male gender previous TB treatment, patients previously on Non-DOTS treatment, incomplete previous TB treatment, positive contact history of MDR-TB cases, presence of associated co-morbidities and substance abuse was significantly associated with MDR-TB patients than Non-MDR-TB patients (p<0.05).
Metrics
References
Mohan A, Sharma SK. Epidemiology. In: Sharma SK Mohan A, editors. Tuberculosis. New Delhi: Jaypee Brothers Medical Publishers; 2001: 14-29.
Sharma SK, Mohan A. Multidrug-resistant tuberculosis. Mediquest 1995.13:1-11.
Mohan A, Sharma SK. History. In: Sharma SK, Mohan A, editors. Tuberculosis. New Delhi: Jaypee Brothers Medical Publishers; 2001: 5-13.
Global Tuberculosis Report 2014.WHO.Chapter-1; Introduction; 2014: 1.
Global Tuberculosis Report 2014. WHO.Chapter-2; The burden of disease caused by TB; 2014: 8.
Migliori GB, Loddenkemper R, Blasi F, Raviglione MC. 125 years after Robert Koch’s discovery of the tubercle bacillus: the new XDR-TB threat. Is ‘‘science’’ enough to tackle the epidemic? Eur Respir J. 2007;29:423–7.
Drug Resistant TB in India; Key Massages; No.2. Institute of Medicine (US). Washington (DC): National Academies Press (US); 2012. Available at: https://www.ncbi.nlm.nih.gov/books/NBK100386/ Accessed on 7 April 2017.
Marahatta SB. Multidrug resistant tuberculosis burden and risk factors: An update. Kathmandu University Med J. 2010;8:116 -25.
Faustini A, Hall JA, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61:158-63.
Casal M, Vaquerom H. Rinder H. A Case-Control study for multidrug-resistant tuberculosis: Risk factors in four European Countries. Microb Drug Resist. 2005;11:62-7.
Franke M, Appleton SC, Bayona J, Bayona J, Arteaga F, Palacios E, et al. Risk factors and mortality associated with default from multidrug- resistant tuberculosis treatment. Clin Infect Dis 2008;46(12):1844–51.
Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. African Health Sci. 2015;15(2):369.
Agrawal SS, Nagar SS, Makadia BK. Assesment of one year of RNTCP. Indian J Community Med. 2014;29(4):164.
Elmi OS, Hasan H, Abdullah S, Mat Jeab MZ, Bin Alwi Z, Naing NN. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. J Infect Dev Ctries. 2015;9(10):1076-85.
Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2014;18(10):1195–1201.
Rifat M, Milton AH, Hall J, Oldmeadow C, Islam MA, Husain A, et al. Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors. PLoS One. 2014;9(8):e105214.
Alrajhi AA, Abdulwahab S, Almodovar E, Al-Abdely HM, et al. Risk factors for drug resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J. 2002;23(3):305-10.
Bhatt G, Vyas S, Trivedil K. An Epidemiological study of Multi Drug Resistant tuberculosis cases registered under Revised National Tuberculosis control Programme of Ahmadabad city. Indian J Tuberc. 2012;59:18-27.
Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, Rüsch-Gerdes S, et al. A Case-Control Study for Multidrug-Resistant Tuberculosis: Risk Factors in Four European Countries. Microb Drug Resist. 2005;11(1):62-7.
Datta BS, Hassan G, Kadri SM, Qureshi W, Kamili MA, Singh H, et al. Multidrug-Resistant and extensively drug resistant tuberculosis in Kashmir, India. J Infect Dev Ctries. 2010;4(1):19-23.
Downloads
Published
How to Cite
Issue
Section
